Science & Technology
SBIR Phase I:Hybrid DNA-protein quantification platform for point-of-care diagnosis of syphilis and human immunodeficiency viruses (HIV)
National Science Foundation
Opportunity #: 2232930
Award Ceiling
$256K
Award Floor
$256K
Close Date
Jul 31, 2024
Total Funding
$256K
Expected Awards
1
Posted Date
Feb 1, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-2232930
Description
SBIR Phase Phase I award: "SBIR Phase I:Hybrid DNA-protein quantification platform for point-of-care diagnosis of syphilis and human immunodeficiency viruses (HIV)" awarded to Prompt Diagnostics, Inc. in Baltimore, Maryland. Funded by National Science Foundation. Award amount: $255,667. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.